Day: February 27, 2026

No. 4/2026 – Notice to convene ordinary general meeting 2026

Written by Customer Service on February 27, 2026. Posted in Public Companies.

Nasdaq Copenhagen Nikolaj Plads 6DK-1067 Copenhagen K Copenhagen, 27 February 2026ANNOUNCEMENT no. 4/2026 CEMAT A/SCompany reg. (CVR) no. 24 93 28 18Annual general meeting The Board of Directors hereby convene the annual general meeting of Cemat A/S (the “Company”) for Tuesday, 24 March 2026, at 1:00 pm at the office of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark. Agenda The agenda of the annual general meeting is the following:The management’s report on the Company’s activities during the past financial year.Presentation of the audited annual report for adoption.The Board of Directors’ proposal for appropriation of profit or covering of loss according to the adopted annual report.Presentation...

AEHL Board Approves Digital Asset Strategic Reserve Plan in Support of the “Genius Plan,” Establishing $10 Billion Phased Target

Written by Customer Service on February 27, 2026. Posted in Public Companies.

NEW YORK, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ: AEHL, or the “Company”), today announced that its Board of Directors has formally approved the Company’s Digital Asset Strategic Reserve Plan, establishing a phased target of $10 billion to further support the continued implementation of its “Genius Plan.” The Company stated that the approved target reflects AEHL’s long-term commitment to strategic asset allocation. Beyond expanding asset scale, the initiative is designed to provide stronger capital foundation and structural support for the Genius Plan, while systematically advancing digital asset allocation within the framework of a publicly listed company. Under the approved plan, AEHL intends to pursue its digital asset reserve strategy in a structured and disciplined manner, integrating...

Arbor Realty Trust Reports Fourth Quarter and Full Year 2025 Results and Declares Dividend of $0.30 per Share

Written by Customer Service on February 27, 2026. Posted in Earnings Releases And Operating Results.

Fourth Quarter Highlights:GAAP net income of $0.07 per diluted common share Distributable earnings1 of $0.19, or $0.22 per diluted common share, excluding $5.1 million of net realized losses from the resolution of certain legacy assets previously reserved for Declares cash dividend on common stock of $0.30 per share Agency loan originations of $1.63 billion Structured loan originations of $1.10 billion, our strongest quarter in over three years Issued $400.0 million of 8.50% senior unsecured notes due 2028 Unwound CLO 16 with $482.1 million of outstanding notes generating ~$90 million of liquidity Foreclosed on six loans totaling $139.0 million and sold three real estate owned properties totaling $77.6 million Repurchased $20.0 million of stock at an average price of $7.40 per share, or 64% of book value, between December 2025 and February...

CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates

Written by Customer Service on February 27, 2026. Posted in Earnings Releases And Operating Results.

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk NMIBC expected first half 2026 CORE-008 Cohort CX Phase 2 first results of combination cretostimogene with gemcitabine in high-risk (HR) NMIBC expected first half 2026 Well-positioned to deliver on key milestones with approximately $903.0 million cash, cash equivalents and marketable securities sufficient to fund operations into the first half of 2029IRVINE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today reported financial results for the fourth quarter and year ended December 31, 2025, and provided business updates. “In the coming months, we look forward to sharing topline data from PIVOT-006, the first randomized registrational trial to evaluate an investigational therapy in intermediate-risk...

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

Written by Customer Service on February 27, 2026. Posted in Public Companies.

MINNEAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry. Following the successful November 10, 2025, demonstration of live feeds, subscription access, and AI-driven search at major tradeshows, the Company is actively converting customer evaluations into commercial subscriptions. Early results highlight superior performance, speed and analytical depth, reinforcing OneMedNet’s position for life sciences and healthcare organizations generating real-world evidence (RWE). This launch drives rapid expansion of subscription contracts, including multi-year deals representing millions...

AEHL Confirms Completion of Initial $1 Million Bitcoin Purchase, Officially Launching the “Genius Plan”

Written by Customer Service on February 27, 2026. Posted in Public Companies.

NEW YORK, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ: AEHL, or the “Company”), today confirmed that it has completed its initial $1 million Bitcoin (BTC) purchase. This milestone marks the official implementation phase of the Company’s “Genius Plan.” As previously disclosed, the Genius Plan is designed to integrate structured digital asset allocation with disciplined execution mechanisms, combining volatility management, gain realization, and capital structure optimization into a sustainable capital recycling framework. The initial purchase represents both confirmation of strategic direction and tangible execution. The Company stated that the $1 million allocation serves as the strategic starting point of the Genius Plan. Going forward, AEHL intends to continue advancing its digital asset...

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Written by Customer Service on February 27, 2026. Posted in Public Companies.

CRANFORD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) — Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchange offer by the Company to each holder of its Series C Non-Convertible Redeemable Preferred Stock, $0.01 par value per share (the “Series C Preferred Stock”), to exchange such Series C Preferred Stock for shares of Enzon’s common stock, $0.01 par value per share (the “Common Stock”). After giving effect to the extension, the offer expires one minute after 11:59 p.m., Eastern Time, on March 9, 2026, unless the offer is further extended. Continental Stock Transfer & Trust Company, the depositary for the offer, has advised Enzon that, as of 5:00 p.m., Eastern Time, on February 26, 2026, a total of 12 shares of Series C Preferred Stock had been...

Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026

Written by Customer Service on February 27, 2026. Posted in Public Companies.

SPRING BRANCH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) — Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026. iAccess Alpha Virtual Best Ideas Spring Investment Conference Dates: March 10–11, 2026Location: VirtualPresentation Details: Tuesday, March 10, 2026 at 10:30am ETWebcast Link: https://www.webcaster5.com/Webcast/Page/3157/53626 For more information, please contact your iAccess Alpha representative or email KCSA Strategic Communications at CallanJMB@kcsa.com. About Callan JMB Inc. Callan JMB Inc. is a vertically...

FRO – Q4 2025 Presentation

Written by Customer Service on February 27, 2026. Posted in Public Companies.

Please find enclosed the presentation of Frontline plc´s fourth quarter 2025 results to be held on the webcast / conference call 27 February, 2026 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 – 12 of the Norwegian Securities Trading Act.AttachmentPresentation Q4 2025

Fairfax Completes C$650 Million Senior Notes Offering

Written by Customer Service on February 27, 2026. Posted in Public Companies.

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Feb. 27, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) has completed its previously announced offering (the “Offering”) of (i) C$400 million in aggregate principal amount of 4.40% Senior Notes due 2036 and (ii) an additional C$250 million in aggregate principal amount of its 5.10% Senior Notes due 2055 (collectively, the “Senior Notes”). Together with the previously issued C$300 million aggregate principal amount 5.10% Senior Notes due 2055, there is C$550 million aggregate principal amount of notes of this series outstanding. The Senior Notes were offered through a syndicate of dealers led by BMO Nesbitt Burns Inc., CIBC World Markets Inc., RBC Dominion Securities Inc. and Scotia Capital...

Day: February 27, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals